Alnylam Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
ALNY chart
What traders are saying about $ALNY
Latest postsAlnylam Pharmaceuticals, Inc. news
- Citi Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $320
Moomoo ·
- Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Climbs 1.62% to USD 227.66
Kalkine India ·
- Alnylam Reports Up to 83% Huntingtin Reduction, Eyes 2027 Pivotal Trial
marketbeat.com ·
- Alnylam Pharmaceuticals, Inc.- RNAi Roundtable Transcript
GuruFocus ·
- Alnylam Pharmaceuticals, Inc. (ALNY) stock price, news, quote and history
Yahoo Finance UK ·
- Analysts Estimate Krystal Biotech, Inc. (KRYS) to Report a Decline in Earnings: What to Look Out for
Yahoo Finance ·
- Silver Linings expo draws hundreds of Manchester-area seniors seeking advice on aging
New Hampshire Union Leader ·
- Raymond James sets USD 420.00 target for Alnylam Pharmaceuticals stock
ad-hoc-news.de ·
- Vertex Stock Looks Expensive. Does It Get Cheaper Ahead?
trefis.com ·
- Alnylam Pharmaceuticals, Inc Estimates – GETTEX:DUL
TradingView ·
- How Much Downside Is Left In Moderna Stock?
trefis.com ·
- Alnylam Announces Positive Initial Phase 1b Data for Brezosiran (ALN-HTT02) Demonstrating Deep and Durable Huntingtin Lowering in Huntington’s Disease
Yahoo Finance ·
Alnylam Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.71B | $2.25B | $1.83B | $1.04B |
| Net income | $313.7M | -$278.2M | -$440.2M | -$1.13B |
| Diluted EPS | $2.33 | $-2.18 | $-3.52 | $-9.30 |
| Total assets (year end) | $4.97B | $4.24B | $3.83B | $3.55B |
| Cash and equivalents (year end) | $1.66B | $966.4M | $812.7M | $866.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Alnylam Pharmaceuticals, Inc.
- Ticker
- ALNY (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Fiscal year end
- December 31
- SEC CIK
- 1178670
- Former names
- ALNYLAM PHARMACEUTICALS INC
Frequently asked questions
What exchange is Alnylam Pharmaceuticals, Inc. listed on?
Alnylam Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ALNY.
What industry is Alnylam Pharmaceuticals, Inc. in?
Alnylam Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Alnylam Pharmaceuticals, Inc. headquartered?
Alnylam Pharmaceuticals, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Alnylam Pharmaceuticals, Inc.'s fiscal year end?
Alnylam Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Alnylam Pharmaceuticals, Inc. report?
Alnylam Pharmaceuticals, Inc. reported $3.71B in revenue for calendar year 2025, according to its SEC filings.